流产威胁和反复流产:关于孕激素治疗和治疗挑战的专家意见
Süleyman Cansun Demir1, Ali Gedikbaşı2, Hakan Timur3
1Çukurova University Faculty of Medicine, Department of Obstetrics and Gynecology, Adana, Turkey.
Turkish journal of obstetrics and gynecology
|September 5, 2023
概括
专家们支持用于威胁性和反复性流产的二二,同意其安全性和指导建议. 然而,关于其在复发病例中的使用以及最佳的施用方法的意见有所不同.
科学领域:
- 生殖医学 生殖医学
- 产科和妇科 产科和妇科
- 临床研究 临床研究
背景情况:
- 在全球范围内,受到威胁和反复流产的流产对身体和情绪造成了重大负担.
- 了解当前的管理策略和知识差距对于改善患者的治疗结果至关重要.
- 需要评估流产管理的医疗方法,特别是在像土耳其这样的特定地区.
研究的目的:
- 探索土耳其流产的后果,挑战和治疗方法.
- 在土耳其专家中评估土耳其专家对威胁和反复流产的管理.
- 将专家意见与现有文献建议进行比较.
主要方法:
- 专家意见会议与6名土耳其围产科医生和产科医生/妇科医生举行.
- 报告中提出了19份关于威胁性和反复性流产管理的陈述.
- 专家们使用5分利克尔特度量表做出回应,并讨论了每个陈述.
主要成果:
- 大多数专家赞成使用孕激素,特别是口服双激素,用于威胁和反复流产.
- 达成一致的协议是关于二二的疗效,安全性和指导方针建议.
- 关于二二在反复流产和特定的服用方案中的有效性,意见各不相同.
结论:
- 二因其在威胁性和复发性流产管理中的有效性和安全性而得到认可.
- 需要遵守指南和进一步研究,以解决流产管理中的不确定性.
- 土耳其国家准则是有必要的,以优化对流产妇女的护理.
更多相关视频
06:49Methods for Studying Uterine Contributions to Pregnancy Establishment in an Ovariectomized Mouse Model
Published on: April 7, 2023
1.7K
07:46Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells
Published on: October 13, 2023
1.3K
相关概念视频
Mitral Valve Prolapse III: Nursing Management
16
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
16
Ovarian Cycle
1.3K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.3K
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
